Short Interest in Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) Drops By 44.7%

Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) was the target of a significant drop in short interest in June. As of June 15th, there was short interest totaling 7,733 shares, a drop of 44.7% from the May 31st total of 13,976 shares. Currently, 1.1% of the shares of the stock are sold short. Based on an average daily volume of 5,224 shares, the short-interest ratio is presently 1.5 days.

Virtus LifeSci Biotech Products ETF Price Performance

BBP stock opened at $99.08 on Friday. Virtus LifeSci Biotech Products ETF has a 52 week low of $58.97 and a 52 week high of $99.08. The firm has a 50-day simple moving average of $87.95 and a 200-day simple moving average of $84.33.

Hedge Funds Weigh In On Virtus LifeSci Biotech Products ETF

A number of hedge funds have recently made changes to their positions in BBP. Comprehensive Financial Planning Inc. PA acquired a new stake in shares of Virtus LifeSci Biotech Products ETF in the fourth quarter worth approximately $557,000. Flow Traders U.S. LLC acquired a new position in Virtus LifeSci Biotech Products ETF in the 2nd quarter valued at $431,000. Finally, Prime Capital Investment Advisors LLC purchased a new position in Virtus LifeSci Biotech Products ETF in the 4th quarter valued at $1,896,000.

About Virtus LifeSci Biotech Products ETF

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.